RNA viruses exhibit extreme variability and rapid evolution, complicating the design of effective vaccines.
No takes yet. Share an insight, caveat, or question.
May require broader or adaptive vaccine strategies now; leaves open optimal platforms for mutable RNA viruses.
Steinhauer et al. (1987) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: